Literature DB >> 21104870

Pseudometabolic presentation of dystrophinopathy due to a missense mutation.

Aravindhan Veerapandiyan1, Vandana Shashi, Yong-Hui Jiang, William Brian Gallentine, Kelly Schoch, Edward Clinton Smith.   

Abstract

Exercise intolerance with myalgia, muscle stiffness, and recurrent rhabdomyolysis due to mutations in the DMD gene can mimic metabolic myopathies leading to delayed or inaccurate diagnoses. In this retrospective chart review, we report 3 unrelated boys with exertional myalgia, muscle stiffness, myoglobinuria, and normal neurological examination due to an identical point mutation in the DMD gene: a hemizygous T-to-C change in exon 15 (c.1724T>C) resulting in an amino acid substitution of leucine to proline at codon 575. Two of the 3 boys had normal dystrophin immunostaining and Western blot analysis in muscle. This missense mutation has been reported twice before, with at least 1 patient exhibiting rhabdomyolysis. Our report, however, is the first to describe in detail the clinical findings associated with this specific mutation. Further studies and clinical reports are needed to better understand the pathogenicity of the mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104870      PMCID: PMC5506871          DOI: 10.1002/mus.21823

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  41 in total

1.  Becker muscular dystrophy with marked divergence between clinical and molecular genetic findings: case series.

Authors:  G P Ramelli; F Joncourt; J Luetschg; J Weis; M Tolnay; J M Burgunder
Journal:  Swiss Med Wkly       Date:  2006-03-18       Impact factor: 2.193

Review 2.  Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.

Authors:  E P Hoffman; L M Kunkel
Journal:  Neuron       Date:  1989-01       Impact factor: 17.173

3.  Detection of deletion in the dystrophin gene of a patient with quadriceps myopathy.

Authors:  D Kumari; M Gupta; S Goyle
Journal:  Neurol India       Date:  2000-03       Impact factor: 2.117

4.  Prognostic factors in mild dystrophinopathies.

Authors:  C Angelini; M Fanin; M P Freda; F Martinello; M Miorin; P Melacini; G Siciliano; E Pegoraro; M Rosa; G A Danieli
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

Review 6.  [Quadriceps myopathy as dystrophin-associated myopathy].

Authors:  H C von Mitzlaff; S Liechti-Gallati; K M Rösler; J M Burgunder
Journal:  Schweiz Med Wochenschr       Date:  1993-10-09

7.  Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients.

Authors:  U Lenk; R Hanke; H Thiele; A Speer
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

10.  Muscle pain as the only presenting symptom in a girl with dystrophinopathy.

Authors:  Berten P Ceulemans; Katrien Storm; Edwin Reyniers; Luc Callewaert; Jean Jacques Martin
Journal:  Pediatr Neurol       Date:  2008-01       Impact factor: 3.372

View more
  7 in total

1.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

2.  Fine mapping of hydrophobic contacts reassesses the organization of the first three dystrophin coiled-coil repeats.

Authors:  Dominique Mias-Lucquin; Angélique Chéron; Elisabeth Le Rumeur; Jean-François Hubert; Olivier Delalande
Journal:  Protein Sci       Date:  2019-01-14       Impact factor: 6.725

3.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

4.  Mutations in GMPPB Presenting with Pseudometabolic Myopathy.

Authors:  Chiara Panicucci; Chiara Fiorillo; Francesca Moro; Guja Astrea; Giacomo Brisca; Federica Trucco; Marina Pedemonte; Paola Lanteri; Lucia Sciarretta; Carlo Minetti; Filippo M Santorelli; Claudio Bruno
Journal:  JIMD Rep       Date:  2017-04-30

5.  CUGC for Duchenne muscular dystrophy (DMD).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

Review 6.  Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm.

Authors:  Federica Rachele Danti; Federica Invernizzi; Isabella Moroni; Barbara Garavaglia; Nardo Nardocci; Giovanna Zorzi
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

7.  A Novel Mutation in N-Terminal Actin-Binding Domain of the DMD Gene Presenting Becker Muscular Dystrophy as Recurrent Exertional Rhabdomyolysis: A Case Report.

Authors:  Jong-Mok Lee
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.